Ursolic Acid Increases Strength in mdx Mice Model and may Decrease Fibrosis Deposition by TGF-ß Downregulation

SUMMARY: Dystrophin disfunction results in sarcolemma destabilization, leading muscle cell damage by continuous degeneration cycles and limited regeneration. In muscle dystrophy, caused by dystrophin dysfunction, inflammation, necrosis and fibrosis are pathophysiological muscle function loss characteristics. As a genetic disease, this muscle dystrophy has no cure, however, advances in drug therapy using glucocorticoids can decrease the disease progression. Subsequently, alternative therapies were studied, such as ursolic acid (UA), that inhibits muscle atrophy and increases muscle mass and strength. Herein, we used 10 mg/kg daily supplementation in mdx mice for 4 weeks to evaluate serum creatine phosphokinase (CPK), muscle strength (Kondziela test), muscular organization (histology) and expression of fibrosis related genes (TGF-ß, TNF-α, mstn and ostn). UA supplementation increased muscle morphological organization, motor strength and decreased muscular TGF-ß expression. Altogether, the gene expression profile, histological organization and strength could suggest that UA treatment did not stop the fibrogenesis but decreased its progress.

Bibliographic Details

Main Authors:	Barreto,Rodrigo S. N, Oliveira,Lilian J, Matias,Gustavo S. S, Ribeiro,Rafaela R, Pimentel,Concepta M. M, Feder,David, Miglino,Maria Angelica
Format:	Digital revista
Language:	English
Published:	Sociedad Chilena de Anatomía 2022
Online Access:	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-95022022000100168
Tags:	Add Tag No Tags, Be the first to tag this record!